Find uplifting stories about heroes, innovations, and solutions
1840 results for "gavi vaccine alliance"
Zimbabwe is strengthening its healthcare system through an expanded partnership with Gavi, focusing on protecting women and girls from preventable cervical cancer. Remote communities are already seeing better-equipped health facilities and improved access to life-saving vaccines.
A global vaccine alliance just secured $300 million in new partnerships to bring life-saving vaccines to remote African communities. The funding will help 140,000 children in cocoa-farming regions access immunizations in the next three years.
Rwanda is positioning itself as a regional leader in pandemic preparedness, backed by its world-class health systems and impressive 90% vaccine coverage rates. The head of Gavi, the Vaccine Alliance, says the East African nation has what it takes to lead the continent's emergency response efforts.
The same technology that revolutionized COVID vaccines just earned approval for seasonal flu, potentially ending decades of hit-or-miss protection. Moderna's mRNA flu shot marks a new era in how we fight one of America's most common infectious diseases.
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
South Carolina's largest measles outbreak in decades has officially ended after nearly 1,000 cases, and there's encouraging news: vaccination rates are climbing both locally and nationwide. Health officials say the outbreak may have reminded parents why vaccines matter.
South Africa is preparing to roll out a groundbreaking tuberculosis vaccine for adults that could become the first new TB vaccine in over a century. The M72/AS01E vaccine is currently in Phase 3 trials across five countries and could help eliminate TB as a public health threat by 2030.
Scientists at Washington University have created a nose spray vaccine that completely protected mice and hamsters from bird flu infection, offering hope for preventing the next pandemic. The vaccine works better than traditional flu shots and stays effective even in people who've had previous flu vaccines.
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
California health officials are encouraging at-risk residents to get vaccinated against mpox as case rates have more than quadrupled compared to last year. The vaccine provides strong protection against both strains of the virus, and most new infections are happening in unvaccinated people.
A tetanus-diphtheria vaccine that stays effective for two years without refrigeration has passed its first human safety trial. The breakthrough could help vaccines reach millions in remote areas where keeping medicines cold is nearly impossible.
The same groundbreaking technology that created COVID vaccines just earned approval for fighting the flu. Moderna's new mRNA flu shot showed better protection than standard vaccines and will be available for the 2026-2027 flu season.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
African countries have prevented nearly one million cervical cancer deaths through expanded HPV vaccination programs since 2019, while new malaria vaccines are saving thousands of children across 25 nations. These historic health wins are generating $1.8 billion in economic benefits, though funding gaps now threaten to slow the momentum.
Scientists are fast-tracking three promising vaccines to fight the Ebola outbreak in Congo and Uganda, with clinical trials starting within months. New funding of $62 million is speeding up development of the first vaccines specifically designed for the Bundibugyo virus strain.
Iceland, Portugal, and Norway have reached the ambitious target of vaccinating 90% of girls against HPV by age 15, bringing cervical cancer elimination within reach. Since 2020, every European country has reported declining cervical cancer rates among vaccinated women. #
An FDA committee greenlighted next year's flu vaccine formulation this week, maintaining the proven update process while vaccine policy debates swirl in Washington. The decision keeps Americans on track for seasonal flu protection.
South Africa is expanding its lifesaving HPV vaccination campaign to reach every girl in the country, protecting them from cervical cancer that kills over 3,000 women annually. Since 2014, the program has already vaccinated 3.6 million girls with more than 7.2 million doses administered.
A groundbreaking tuberculosis vaccine currently in final trials could become the first new TB vaccine in over a century. South Africa is already preparing to roll it out if approved, potentially transforming the fight against a disease that still claims countless lives.
A global vaccination campaign has delivered over 100 million life-saving vaccine doses to children who missed shots during the pandemic, marking the largest catch-up effort in history. The Big Catch-Up reached 18.3 million children across 36 countries, with 12.3 million receiving their very first vaccines.
Showing 20 of 1840